Maine 2025-2026 Regular Session

Maine House Bill LD887

Introduced
3/4/25  
Refer
3/4/25  
Refer
3/4/25  

Caption

An Act to Make Manufacturers Responsible for Proper Disposal of Abortion Drugs and Require a Health Care Provider to Be Physically Present During a Chemical Abortion

Impact

If enacted, LD887 will likely have significant implications for the practice of chemical abortions within the state. By requiring healthcare providers to follow stringent protocols, the bill aims to enhance patient safety and ensure proper handling of medical waste. The bill also places liability on manufacturers for the proper disposal of abortion drugs and the mitigation of any environmental hazards caused by improper disposal. This creates a framework for more responsible practices surrounding abortion drug management, particularly regarding the environmental impact of endocrine disruptors.

Summary

LD887 is a legislative document aimed at regulating the disposal of abortion drugs and ensuring that health care providers are physically present during chemical abortions. The bill mandates that healthcare providers must conduct a physical examination of the patient, be present at the location of the abortion, schedule a follow-up visit within seven days, and provide a catch kit and medical waste bag for safe disposal. This bill categorizes violations as a Class C crime, indicating a serious approach to compliance with the regulations outlined in the bill.

Sentiment

Overall, the sentiment surrounding LD887 is expected to be polarized. Supporters argue that the bill is a necessary move to ensure the safety and health of patients undergoing chemical abortions and to provide a structured approach to medical waste disposal. Conversely, opponents may view it as adding unnecessary regulations that could limit access to abortion services, particularly in areas where healthcare resources are limited. This tension reflects broader societal debates about reproductive rights and healthcare access.

Contention

The most notable point of contention surrounding LD887 focuses on the balance between public health and access to abortion services. Proponents of the bill assert that it is critical to enforce strict regulations to protect patient safety and the environment from the impacts of abortion drug disposal. In contrast, critics may highlight the potential barriers this could create for individuals seeking abortions, suggesting that the requirements might deter some healthcare providers from offering such services due to the regulatory burden.

Companion Bills

No companion bills found.

Previously Filed As

ME HB555

Generally revise laws related to chemical abortion

ME SB479

Generally revise laws related to chemical abortion

ME H3092

Chemically Induced Abortions

ME HB1844

In abortion, further providing for definitions and for medical consultation and judgment.

ME HB629

Ending Chemical Abortions Act of 2025

ME HB1525

Protecting Life from Chemical Abortions Act

ME S2259

Codifies authority for certain health care providers to provide abortions and clarifies certain operational requirements for abortion facilities.

ME A2217

Codifies authority for certain health care providers to provide abortions and clarifies certain operational requirements for abortion facilities.

ME SSB3115

A bill for an act relating to abortions including informed consent, dispensing abortion-inducing drugs, and reporting abortion-inducing drug complications.

ME HB1702

Relative to notice requirements and enforcement for pharmacies dispensing medications intended to induce chemical abortions.

Similar Bills

No similar bills found.